US Patent 11116835 Epstein Barr virus antibodies, vaccines, and uses of the same

Patent 11116835 was granted and assigned to Fred Hutchinson Cancer Research Center on September, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Fred Hutchinson Cancer Research Center

Current Assignee

Fred Hutchinson Cancer Research Center

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11116835

Date of Patent

September 14, 2021

Patent Application Number

20180510

Date Filed

May 10, 2018

Patent abstract

Anti-Epstein Barr Virus (EBV) antibodies and vaccines are described herein. The antibodies and vaccines can be used to treat and/or reduce the risk of EBV infection and to treat and/or reduce the risk of complications associated with EBV infection, such as infectious mononucleosis, lymphoproliferative disorders, carcinomas, and smooth muscle tumors.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11116835 Epstein Barr virus antibodies, vaccines, and uses of the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API